Neuland Labs.

{
  "main_header": {
    "sid": 229993,
    "name": "Neuland Labs.",
    "stock_name": "Neuland Labs.",
    "full_name": "Neuland Laboratories Ltd",
    "name_url": "stocks-analysis/neuland-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "14,914.45",
    "chg": 180.95,
    "chgp": "1.23%",
    "dir": 1,
    "prev_price": "14,733.50",
    "mcapval": "19,135.07 Cr",
    "mcap": "Small Cap",
    "scripcode": 524558,
    "symbol": "NEULANDLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE794A01010",
    "curr_date": "Apr 10",
    "curr_time": "",
    "bse_nse_vol": "35.16 k",
    "exc_status": "Active",
    "traded_date": "Apr 10, 2026",
    "traded_date_str": "2026 04 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuland-labs-229993-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Neuland Laboratories Ltd Surges 7.33% to Day's High of Rs 14077.3 — Outperforms Sector by 6.06 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-intraday-high-with-733-surge-on-8-april-2026-3938006",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NeulandLaborato_priceRelatedfactors_3938006.png",
        "date": "2026-04-08 15:30:44",
        "description": "The Sensex advanced 4.03% on 8 Apr 2026, yet Neuland Laboratories Ltd outpaced the broader market with a 7.33% gain, reaching an intraday high of Rs 14,077.3. This 6.06-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift rather than a mere market tailwind."
      },
      {
        "title": "Neuland Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-3935682",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NeulandLaborato_mojoScore_3935682.png",
        "date": "2026-04-07 08:10:32",
        "description": "Neuland Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift driven primarily by technical indicators, even as fundamental financial metrics continue to pose concerns. The company’s recent performance across quality, valuation, financial trends, and technicals has prompted analysts to revise their outlook, balancing cautious optimism with persistent challenges in profitability and growth."
      },
      {
        "title": "Neuland Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-sees-technical-momentum-shift-amid-mixed-indicators-3935032",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NeulandLaborato_technicaldot_3935032.png",
        "date": "2026-04-07 08:00:46",
        "description": "Neuland Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a robust 4.93% gain in the latest session, the stock’s technical indicators present a complex picture, reflecting both cautious optimism and lingering bearish pressures."
      },
      {
        "title": "Neuland Laboratories Ltd Surges 7.15% to Day's High of Rs 13,464 — Outperforms Sector by 8.32 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-intraday-high-with-715-surge-on-6-april-2026-3934435",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NeulandLaborato_priceRelatedfactors_3934435.png",
        "date": "2026-04-06 12:15:43",
        "description": "The Sensex declined by 0.25% on 6 Apr 2026, while Neuland Laboratories Ltd surged 7.15%, marking a remarkable 8.32-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This strong single-session gain stands out amid a broadly weak market backdrop, signalling a stock-specific momentum shift rather than a general market rally."
      },
      {
        "title": "Neuland Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-strong-sell-3922665",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NeulandLaborato_mojoScore_3922665.png",
        "date": "2026-03-29 10:10:37",
        "description": "Neuland Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Neuland Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-strong-sell-3898294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NeulandLaborato_mojoScore_3898294.png",
        "date": "2026-03-18 10:11:11",
        "description": "Neuland Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Neuland Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-strong-sell-3877795",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NeulandLaborato_mojoScore_3877795.png",
        "date": "2026-03-07 10:10:38",
        "description": "Neuland Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Neuland Laboratories Falls 2.99%: 3 Key Technical and Fundamental Factors Driving the Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-falls-299-3-key-technical-and-fundamental-factors-driving-the-decline-3863179",
        "imagepath": "",
        "date": "2026-03-01 11:01:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Feb:</strong> Downgrade to Sell rating announced amid financial and technical weakness</p>\n                    <p><strong>18 Feb:</strong> Technical momentum shifts to sideways with mixed indicator signals</p>\n                    <p><strong>20 Feb:</strong> Mildly bearish technical shift amid market volatility and price decline</p>\n                    <p><strong>20 Feb:</strong> Week closes at Rs.12,654.10 (-2.99%) vs Sensex +0.39%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.13,242.00</div></div>\n                    <div class=\"stat-item\"><div cla..."
      },
      {
        "title": "Neuland Laboratories Gains 1.21%: 4 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-gains-121-4-key-factors-driving-the-weeks-mixed-momentum-3862734",
        "imagepath": "",
        "date": "2026-02-28 17:08:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Feb:</strong> Intraday high surge of 7.89% to Rs.13,652.75</p>\n                    <p><strong>23 Feb:</strong> Formation of Death Cross signalling bearish trend</p>\n                    <p><strong>24 Feb:</strong> Downgrade to Strong Sell amid deteriorating fundamentals</p>\n                    <p><strong>24 Feb:</strong> Shift from mildly bearish to bearish technical trend</p>\n                    <p><strong>27 Feb:</strong> Week closes at Rs.12,806.85 (+1.21%) outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.12,654.10</div></div>\n  ..."
      }
    ],
    "total": 752,
    "sid": "229993",
    "stock_news_url": "https://www.marketsmojo.com/news/neuland-laboratories-229993"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "02-Apr-2026",
      "details": "Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "01-Apr-2026",
      "details": "Press Release",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
      "datetime": "27-Mar-2026",
      "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 26 2026 for Davuluri Rao",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has declared <strong>120%</strong> dividend, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14",
          "dt": "2014-08-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Neuland Laboratories Ltd Surges 7.33% to Day's High of Rs 14077.3 — Outperforms Sector by 6.06 Percentage Points

2026-04-08 15:30:44

The Sensex advanced 4.03% on 8 Apr 2026, yet Neuland Laboratories Ltd outpaced the broader market with a 7.33% gain, reaching an intraday high of Rs 14,077.3. This 6.06-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift rather than a mere market tailwind.

Read full news article

Neuland Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-04-07 08:10:32

Neuland Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift driven primarily by technical indicators, even as fundamental financial metrics continue to pose concerns. The company’s recent performance across quality, valuation, financial trends, and technicals has prompted analysts to revise their outlook, balancing cautious optimism with persistent challenges in profitability and growth.

Read full news article

Neuland Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Indicators

2026-04-07 08:00:46

Neuland Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a robust 4.93% gain in the latest session, the stock’s technical indicators present a complex picture, reflecting both cautious optimism and lingering bearish pressures.

Read full news article

Neuland Laboratories Ltd Surges 7.15% to Day's High of Rs 13,464 — Outperforms Sector by 8.32 Percentage Points

2026-04-06 12:15:43

The Sensex declined by 0.25% on 6 Apr 2026, while Neuland Laboratories Ltd surged 7.15%, marking a remarkable 8.32-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This strong single-session gain stands out amid a broadly weak market backdrop, signalling a stock-specific momentum shift rather than a general market rally.

Read full news article

Neuland Laboratories Ltd is Rated Strong Sell

2026-03-29 10:10:37

Neuland Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Neuland Laboratories Ltd is Rated Strong Sell

2026-03-18 10:11:11

Neuland Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Neuland Laboratories Ltd is Rated Strong Sell

2026-03-07 10:10:38

Neuland Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Neuland Laboratories Falls 2.99%: 3 Key Technical and Fundamental Factors Driving the Decline

2026-03-01 11:01:02

Key Events This Week

16 Feb: Downgrade to Sell rating announced amid financial and technical weakness

18 Feb: Technical momentum shifts to sideways with mixed indicator signals

20 Feb: Mildly bearish technical shift amid market volatility and price decline

20 Feb: Week closes at Rs.12,654.10 (-2.99%) vs Sensex +0.39%

Week Open

Rs.13,242.00

Read full news article

Neuland Laboratories Gains 1.21%: 4 Key Factors Driving the Week’s Mixed Momentum

2026-02-28 17:08:42

Key Events This Week

23 Feb: Intraday high surge of 7.89% to Rs.13,652.75

23 Feb: Formation of Death Cross signalling bearish trend

24 Feb: Downgrade to Strong Sell amid deteriorating fundamentals

24 Feb: Shift from mildly bearish to bearish technical trend

27 Feb: Week closes at Rs.12,806.85 (+1.21%) outperforming Sensex

Week Open

Rs.12,654.10

...

Read full news article

View All News